Biotech
SubsectorHealthcare
Minutes holds 16 developments and 13 deals in Biotech, across 20 companies, recorded from September 2026.
Intelligence
Related subsectors
Deals in Biotech
| Company | Deal | Amount | Counterparties | Date ↓ | Status |
|---|---|---|---|---|---|
| Rewind TherapeuticsBiotech | Funding | Not recorded | Not recorded | 6 Oct | Closed |
| Spyre TherapeuticsBiotech | FundingPublic offering | $350M | Not recorded | 5 Oct | Closed |
| Celaid TherapeuticsBiotech | FundingSeries B second close | JPY 400M | Investors Shionogi & Co., Ltd., Teikoku Ventures | 4 Oct | Closed |
| Astrocyte PharmaceuticalsBiotech | FundingSeries B | $9.5M | Led by DeepWork CapitalWith MintPharma Capital, Waterstar Capital +2 | 30 Sep | Closed |
| Aptadir TherapeuticsBiotech | FundingSeed | €40M | Led by 4BIO CapitalWith EXTEND | 29 Sep | Closed |
| AvenCell TherapeuticsBiotech | FundingRoyalty financing plus Series C | Up to $47M | Investors Ligand Pharmaceuticals | 24 Sep | Announced |
| HCW BiologicsBiotech | FundingPrivate placement | $1.5M | Not recorded | 24 Sep | Announced |
| CelularityBiotech | Debt | At least $10M | Not recorded | 24 Sep | Closed |
| Psyence LabsBiotech | FundingStrategic investment | Up to $5M | Investors Psyence BioMed | 23 Sep | Announced |
| Theravance BiopharmaBiotech | Acquisition | Not recorded | Acquired by Zymeworks | 23 Sep | Closed |
- Celaid TherapeuticsJPY 400MFundingSeries B second close, with Shionogi & Co., Ltd. +1Biotech · 4 Oct · Closed
- AvenCell TherapeuticsUp to $47MFundingRoyalty financing plus Series C, with Ligand PharmaceuticalsBiotech · 24 Sep · Announced
Activity
Developments in Biotech
Past 3 months in Activity →Zymeworks buys Theravance Biopharma
Deal · AcquisitionZymeworks, Theravance Biopharma, +1BiotechGlobeNewswire